(Hypertension. 2001;37:710.)
© 2001 American Heart Association, Inc.
Scientific Contributions |
From the Cardiovascular Research Institute COEUR, Departments of Pharmacology (J.J.S., P.R.S., A.H.J.D.), Internal Medicine (J.J.S., F.H.M.D., M.A.D.H.S.), and Biochemistry (J.M.J.L.), Erasmus University Rotterdam, The Netherlands.
Correspondence to Dr A.H. Jan Danser, Department of Pharmacology, Room EE1418b, Erasmus University Rotterdam, Dr Molewaterplein 50, 3015 GE Rotterdam, The Netherlands. E-mail danser{at}farma.fgg.eur.nl
Cardiomyocytes bind, internalize, and activate recombinant human prorenin through mannose 6-phosphate/insulin-like growth factor II (M6P/IGFII) receptors. To investigate whether this also applies to native human prorenin, neonatal rat myocytes were incubated for 4 hours at 37°C with various prorenin-containing human body fluids. Uptake and activation by M6P/IGFII receptors were observed for plasma prorenin from subjects with renal artery stenosis and/or hypertension and for follicular fluid prorenin. The total amount of cellular renin and prorenin (expressed as percentage of the levels of renin and prorenin in the medium) after 4 hours of incubation was 4 to 10 times lower than after incubation with recombinant human prorenin. Although plasma contains alkaline phosphatases capable of inactivating the M6P label as well as soluble M6P/IGFII receptors that block prorenin binding in a competitive manner and proteins (eg, insulin, IGFII) that increase the number of cell-surface M6P/IGFII receptors, these factors were not responsible for the modest uptake of native human prorenin. Uptake did not occur during incubation of myocytes with plasma prorenin from anephric subjects or with amniotic fluid prorenin, and this was not due to the presence of excessively high levels of M6P/IGFII receptors and/or phosphatase activity in these fluids. In conclusion, myocytes are capable of binding, internalizing, and activating native human prorenin of renal and ovarian origin through M6P/IGFII receptors. Differences in prorenin glycosylation and/or phosphorylation as well as the concentration of soluble M6P/IGFII receptors and growth factors affecting cell-surface M6P/IGFII receptor density determine the amount of prorenin entering the heart and thus cardiac angiotensin II production.
Key Words: myocytes receptors, angiotensin II insulin growth factor renin
This article has been cited by other articles:
![]() |
G. Nguyen and A. H. J. Danser Prorenin and (pro)renin receptor: a review of available data from in vitro studies and experimental models in rodents Exp Physiol, May 1, 2008; 93(5): 557 - 563. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. R. Stankovic, N. D.L. Fisher, and N. K. Hollenberg Prorenin and Angiotensin-Dependent Renal Vasoconstriction in Type 1 and Type 2 Diabetes J. Am. Soc. Nephrol., December 1, 2006; 17(12): 3293 - 3299. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Paul, A. Poyan Mehr, and R. Kreutz Physiology of local Renin-Angiotensin systems. Physiol Rev, July 1, 2006; 86(3): 747 - 803. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Stubbs and S. L Skinner Lectin chromatography of extrarenal renin protein in human plasma and tissues: Potential endocrine function via the renin receptor Journal of Renin-Angiotensin-Aldosterone System, December 1, 2004; 5(4): 189 - 196. [Abstract] [PDF] |
||||
![]() |
M. C. Prieto-Carrasquero, L. M. Harrison-Bernard, H. Kobori, Y. Ozawa, K. S. Hering-Smith, L. L. Hamm, and L. G. Navar Enhancement of Collecting Duct Renin in Angiotensin II-Dependent Hypertensive Rats Hypertension, August 1, 2004; 44(2): 223 - 229. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. F. Pedersen, O. B. Paulson, A. H. Nielsen, and S. Strandgaard Effect of nephrectomy and captopril on autoregulation of cerebral blood flow in rats Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H1097 - H1104. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Tallaj, C.-C. Wei, G. H. Hankes, M. Holland, P. Rynders, A. R. Dillon, J. L. Ardell, J. A. Armour, P. A. Lucchesi, and L. J. Dell'Italia {beta}1-Adrenergic Receptor Blockade Attenuates Angiotensin II-Mediated Catecholamine Release Into the Cardiac Interstitium in Mitral Regurgitation Circulation, July 15, 2003; 108(2): 225 - 230. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Wylie, D. J. Pulford, A. J. McVie-Wylie, R. A. Waterland, H. K. Evans, Y.-T. Chen, C. M. Nolan, T. C. Orton, and R. L. Jirtle Tissue-Specific Inactivation of Murine M6P/IGF2R Am. J. Pathol., January 1, 2003; 162(1): 321 - 328. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Saris, M. M.E.D. van den Eijnden, J. M.J. Lamers, P. R. Saxena, M. A.D.H. Schalekamp, and A.H. J. Danser Prorenin-Induced Myocyte Proliferation: No Role for Intracellular Angiotensin II Hypertension, February 1, 2002; 39(2): 573 - 577. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |